James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 2,800 shares at $52.80 ($148K) on 2026-03-11, disclosed to the SEC on 2026-03-12.
Seasonal sale ($148k) by General Counsel and Secretary — this insider has traded CRSP in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| CRSP | SELL | 2026-03-24 | $149K | — | Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |